Status:
COMPLETED
Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients
Lead Sponsor:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
Further knowledge regarding sequelae in severe COVID-19 patients who have required ICU admission for invasive mechanical ventilation is still needed. Available evidence suggests ongoing respiratory im...
Detailed Description
PURPOSE: To evaluate post-ICU clinical outcomes in severe COVID-19 ICU survivors. DESIGN: A prospective observational study conducted in public hospital in Madrid, Spain. METHODS: Participants: pat...
Eligibility Criteria
Inclusion
- ⋧18 years old,
- subjects diagnosed with COVID-19 confirmed by positive SARS-CoV-2 PCR testing who require admission to ICU for invasive mechanical ventilation
- invasive ventilation \> 24 hours.
Exclusion
- pre-existing cognitive impairment,
- communication/language barrier
- any concurrent physical or mental health condition/ impairment that prevents subjects from taking part in evaluations or providing informed consent
- loss of independent walking ability (with or without walking aids) prior to hospitalisation defined by a score of ≤2 on the mobility item of the modified Barthel Index,
- pregnancy,
- any injuries/surgery that requires medical bed rest.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04853940
Start Date
January 1 2021
End Date
January 1 2022
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ICU. Ramón y Cajal University Hospital
Madrid, Spain, 28034